NL

Bartholomeus Cjm Fauser

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bartholomeus Cjm Fauser. Retrieved from https://idiyas.com/inventor/bartholomeus-cjm-fauser-cocqnwc1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Bartholomeus Cjm Fauser: Innovator in Women's Health

Introduction

Bartholomeus Cjm Fauser is a notable inventor based in the Netherlands. He has made significant contributions to the field of women's health, particularly in the treatment of excessive uterine bleeding. His innovative approach focuses on the use of progesterone antagonists and selective progesterone receptor modulators.

Latest Patents

Fauser's most recent patent is titled "Progesterone Antagonist And Selective Progesterone Modulator In The Treatment Of Excessive Uterine Bleeding." This invention addresses the need for effective medication to treat or prevent excessive uterine bleeding in women suffering from various coagulation disorders. The treatment duration can range from 1 day to 180 days, showcasing the flexibility and potential impact of his work.

Career Highlights

Throughout his career, Fauser has been associated with Preglem SA, a company dedicated to advancing women's health solutions. His work has been instrumental in developing therapies that improve the quality of life for women facing challenging health issues.

Collaborations

Fauser collaborates with Ernest Loumaye, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in driving forward medical advancements.

Conclusion

Bartholomeus Cjm Fauser's contributions to women's health through his innovative patents highlight his commitment to improving medical treatments. His work continues to pave the way for advancements in the management of uterine bleeding, ultimately benefiting many women worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…